Corcept Therapeutics Overview

  • Founded
  • 1998
Founded
  • Status
  • Public
  • Employees
  • 206
Employees
  • Stock Symbol
  • CORT
Stock Symbol
  • Share Price
  • $28.14
  • (As of Friday Closing)

Corcept Therapeutics General Information

Description

Corcept Therapeutics Inc is engaged in the discovery, development, and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders by modulating the effects of cortisol.

Contact Information

Website
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Stock Exchange
NAS
Primary Office
  • 149 Commonwealth Drive
  • Menlo Park, CA 94025
  • United States
+1 (650) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Corcept Therapeutics Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$28.14 $27.62 $9.70 - $28.36 $3.27B 116M 939K $0.96

Corcept Therapeutics Financials Summary

In Thousands,
USD
TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 1,609,428 1,151,922 1,347,509 1,985,926
Revenue 356,034 306,486 251,247 159,201
EBITDA 134,944 113,777 89,732 52,961
Net Income 109,398 94,181 75,410 129,122
Total Assets 534,125 412,312 311,694 220,537
Total Debt 3,031 3,461 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Corcept Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Corcept Therapeutics‘s full profile, request access.

Request a free trial

Corcept Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Corcept Therapeutics Inc is engaged in the discovery, development, and commercialization of drugs for the treatment of s
Pharmaceuticals
Menlo Park, CA
206 As of 2019
00000
00000000000 00000

0000 000

or sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna
0000000000000
Cambridge, MA
000 As of 0000
00.000
000000000 00.000

00000000

quip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum
0000000000000
Pasadena, CA
000 As of 0000
00.000
000000 - 000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Corcept Therapeutics Competitors (16)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
SAGE Therapeutics Formerly VC-backed Cambridge, MA 000 00.000 000000000 00.000
000000000 00000000 Corporation Pasadena, CA 000 00.000 000000 - 000 00.000
000000000000 Formerly VC-backed South San Francisco, CA 000 00000 000000000 00000
000000000 00000000 Formerly VC-backed Cambridge, MA 00 00000 000000 - 000 00000
00000000 000000000 Formerly VC-backed Ann Arbor, MI 000 00000 00000000000 00000
You’re viewing 5 of 16 competitors. Get the full list »

Corcept Therapeutics Executive Team (7)

Name Title Board Seat Contact Info
Joseph Belanoff MD Chief Executive Officer & Founder
Charles Robb JD Chief Financial Officer
Hazel Hunt Ph.D Director, Research
Daniel Bradbury Independent Director
You’re viewing 4 of 7 executive team members. Get the full list »

Corcept Therapeutics Board Members (9)

Name Representing Role Since
Daniel Swisher Jr. Self Board Member 000 0000
David Mahoney Self Board Member 000 0000
George Baker Jr. Self Board Member 000 0000
Gregg Alton JD Corcept Therapeutics Board Member 000 0000
James Wilson Self Chairman & Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Corcept Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial